Physician profile
Jon Griffiths
NPI 1972508778
$547.61
in general payments reported to CMS, 2019-2025
12 companies · $202 in 2025
The $202 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.28 · 2021: $26.11 · 2022: $12.78 · 2023: $122 · 2024: $172 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $496.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $496.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $164.09 | 2023-2025 | Qelbree, Qelbree |
| Corium, LLC | $105.62 | 2022-2024 | Azstarys |
| Collegium Pharmaceutical, INC. | $61.56 | 2025 | Jornay Pm |
| Alk-Abello, INC | $37.50 | 2025 | Neffy |
| Merck Sharp & Dohme LLC | $31.52 | 2024-2025 | Gardasil 9, Enflonsia, Gardasil |
| Sanofi-Aventis U.S. LLC | $29.64 | 2025 | |
| Sobi, INC | $26.11 | 2021 | |
| Glaxosmithkline, LLC. | $22.72 | 2025 | Penmenvy, Bexsero |
| Ironshore Pharmaceuticals INC. | $21.56 | 2024 | |
| Sanofi Pasteur INC. | $19.14 | 2023 | |
| Kaleo, INC. | $15.87 | 2023 | Auvi-Q |
| Tris Pharma INC | $12.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Griffiths listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.